YKT6 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 4.809200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
7.158000E-01
Normal-vs-Stage2
4.422600E-01
Normal-vs-Stage3
9.477600E-01
Normal-vs-Stage4
5.221600E-01
Stage1-vs-Stage2
1.672380E-01
Stage1-vs-Stage3
7.563200E-01
Stage1-vs-Stage4
3.037600E-01
Stage2-vs-Stage3
4.358600E-01
Stage2-vs-Stage4
8.002800E-01
Stage3-vs-Stage4
7.145000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
5.010000E-01
Normal-vs-AfricanAmerican
2.554000E-01
Normal-vs-Asian
5.143200E-01
Caucasian-vs-AfricanAmerican
8.246800E-01
Caucasian-vs-Asian
9.649800E-01
AfricanAmerican-vs-Asian
8.104400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
4.831400E-01
Normal-vs-Female
4.800600E-01
Male-vs-Female
8.922400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
9.870800E-01
Normal-vs-Age(41-60Yrs)
2.255200E-01
Normal-vs-Age(61-80Yrs)
6.533200E-01
Normal-vs-Age(81-100Yrs)
3.938000E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
2.346200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
6.645600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
4.330400E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
6.277000E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
3.307400E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
6.054600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
9.196200E-01
Normal-vs-Daily Drinker
5.186400E-01
Normal-vs-Weekly Drinker
8.794100E-02
Normal-vs-Occasional Drinker
2.610000E-01
Normal-vs-Social Drinker
2.182600E-01
Non Drinker-vs-Daily Drinker
2.730600E-01
Non Drinker-vs-Weekly Drinker
1.017850E-01
Non Drinker-vs-Occasional Drinker
2.420300E-02
Non Drinker-vs-Social Drinker
1.241550E-02
Daily Drinker-vs-Weekly Drinker
2.316200E-01
Daily Drinker-vs-Occasional Drinker
1.936630E-01
Daily Drinker-vs-Social Drinker
1.042020E-01
Weekly Drinker-vs-Occasional Drinker
6.133000E-01
Weekly Drinker-vs-Social Drinker
8.022000E-01
Occasional Drinker-vs-Social Drinker
7.024600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
7.184200E-01
Normal-vs-Grade 2
7.319800E-01
Normal-vs-Grade 3
7.554800E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
6.811600E-01
Grade 1-vs-Grade 3
3.177800E-01
Grade 1-vs-Grade 4
7.184200E-01
Grade 2-vs-Grade 3
2.173400E-01
Grade 2-vs-Grade 4
7.319800E-01
Grade 3-vs-Grade 4
7.554800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
7.341200E-01
Normal-vs-NonDiabetic
3.982600E-01
Diabetic-vs-NonDiabetic
6.259900E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
1.973560E-02
Normal-vs-NoPancreatitis
5.098800E-01
Pancreatitis-vs-NoPancreatitis
4.132100E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
5.372600E-01
Normal-vs-N1
4.524200E-01
N0-vs-N1
1.372150E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
2.683200E-01
Normal-vs-TP53-NonMutant
8.208000E-01
TP53-Mutant-vs-TP53-NonMutant
6.843200E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
